Exercise & Brain Energetics in PD
EBEPD
The Effect of Exercise on Brain Energetics in Parkinson's Disease
1 other identifier
interventional
40
1 country
1
Brief Summary
There is increasing evidence that the usage and delivery of energy to the brain, known as brain energetics, is altered in people with Parkinson's disease (PD). This project will explore whether exercise has a positive impact on brain energetics using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) brain scanning in PD subjects. PD subjects will be scanned before and after a supervised exercise program to investigate the effect of exercise on brain energetics. In a separate study, the investigators will also scan healthy volunteers to compare brain energetics in the healthy brain with the brain energetics data in PD subjects acquired in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Jan 2021
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedStudy Start
First participant enrolled
January 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedNovember 6, 2024
November 1, 2024
4.9 years
June 2, 2020
November 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PET/MRI
CMRO2 will be computed from MRI data and CMRGlu from PET data; their ratio will be used to assess brain energetics.
Six months
Other Outcomes (2)
Clinical measure: motor function
Six months
Clinical measure: cognitive function
Six months
Study Arms (2)
Immediate intervention start: active exercise
ACTIVE COMPARATORImmediately starts the six month intervention of active exercise following the baseline scan.
Delayed intervention start: passive exercise
PLACEBO COMPARATORStarts the six month intervention of active exercise six months after the baseline scan. During the six month delay, participants in this arm undergo passive exercise.
Interventions
Thrice-weekly supervised intense aerobic exercise classes on cycle ergometers, in groups, for six months. Percentage of VO2 max will be used to regulate exercise intensity, based on an initial aerobic exercise test.
Thrice-weekly supervised passive exercise classes consisting of stretching and/or yoga, in groups, for six months.
Eligibility Criteria
You may qualify if:
- Mild to moderate Parkinsonism (Hoehn \& Yahr stages I-III)
- Currently exercise less than 120 minutes per week (PD non-exercisers)
You may not qualify if:
- atypical Parkinson syndrome (progressive supranuclear palsy, multiple system atrophy, drug-induced etc.);
- significant osteoporosis or arthritis;
- history of cancer within 5 years of study participation;
- high dose of radiation from other procedures within the year;
- not able to tolerate being off PD medication for up to 24 hours;
- a female subject who is breast-feeding or pregnant;
- current or past substance use problems;
- serious head injury with loss of consciousness for ≥ 5 minutes;
- people with other chronic diseases such as diabetes, kidney problems, high blood pressure, other known neurological disorders, or heart diseases;
- people who report having a significant respiratory disorder (e.g. asthma, chronic obstructive pulmonary disease (COPD)) or using home oxygen will be excluded to avoid discomfort or breathing difficulties from respiratory manipulations.
- current or past neurological disorder (e.g. strokes, seizures, neurodegenerative disease other than Parkinson's disease);
- current or past psychiatric disorders (e.g. depression, anxiety disorders);
- severe claustrophobia (a fear of closed in spaces);
- weight of more than 158kg (347 lbs);
- inability to lay still for up to 90 minutes;
- +21 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pacific Parkinson's Research Centre
Vancouver, British Columbia, V6T 2B5, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vesna Sossi
University of British Columbia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 11, 2020
Study Start
January 26, 2021
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
November 6, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share